Anika Therapeutics (ANIK) P/FCF US GAAP (year values) |
||||||||
2021 | 2022 | 2023 | 2023 | 2023 | LTM ? | |||
P/FCF | 158.6 | -140.1 | -46.0 | -46.0 | -113.3 | |||
Changes by years, y/y, % | +182% | -188% | -100% | 0% |
Anika Therapeutics. P/FCF
Anika Therapeutics. P/FCF, changes, %
Anika Therapeutics (ANIK) P/FCF US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
P/FCF | -80.1 | -90.1 | 330.9 | -79.2 | -451.4 | -113.3 | ||
Changes by years, y/y, % | -43% | +5% | -1 469% | +221% | +1 731% | |||
Changes by quarters, q/q, % | +74% | +12% | -467% | -124% | +470% |